Author Archives: Arlen Meyers

About Arlen Meyers

Arlen Meyers, MD, MBA is an emeritus professor at the University of Colorado School of Medicine, an instructor at the University of Colorado-Denver Business School and cofounding President and CEO of the Society of Physician Entrepreneurs at www.sopenet.org. Follow along onSubstack.

Filling the biomedical skills gap

GUEST POST from Arlen Meyers

Almost every day, a new technology emerges that challenges doctors and physician entrepreneurs to perfect them. Examples include digital health, blockchain, AI, VR/AR, ICOs, population health analytics, remote sensing and many more. It is unlikely, however, that most doctors will learn any of this in medical school since digital health courses are not required nor are demonstrated competencies at graduation.

A recent report concluded that ,over time, these technologies will have such a significant affect on healthcare that proper training and educational programs will be a necessity.

“The curricula must be multidisciplinary and engage AI developers, implementers, health care system leadership, frontline clinical teams, ethicists, humanists, patients, and caregivers,” the authors wrote. “Each group brings much-needed perspectives, requirements, and expertise.”

The skills gap is not unique to medicine, and, in fact, with low levels of unemployment and many unskilled workers sitting on the sidelines, finding skilled workers is the biggest challenge for employers regardless of the industry.

The reasons are many. The solutions will require a skills gap ecosystem that includes companies, the public sector, the education establishment, service providers, non-profits and students and parents. The model similarly applies to graduate level education since they are not immune to the challenges of finding jobs where they can use their skills, particularly bioscience graduate students expecting find a job in academic research. The ecosystem should have a central nervous system that provides:

  1. A one stop shop to find the resources students need
  2. Teaching the hidden curriculum
  3. Networks and mentors
  4. Experiential learning outside the campus and apprenticeships
  5. Equity, diversity and inclusion
  6. Money, tuition assistance and cheaper student loans with more favorable terms
  7. Alternative business models and pathways to stackable credentials
  8. Reengineering care
  9. New rules and payment schemes
  10. Faculty development help

 

Companies are getting impatient with higher ed and either offering their own courses or working with universities to outsource teaching the information and skills faster and cheaper.

Biomedical education is not keeping up with a rapidly changing world. The result is a skills gap that places patients and the economy at risk. Plugging the gap is too big a job for any one piece to solve. Rather, we need a skills gap ecosystem to fill the slots.

Subscribe to Human-Centered Change & Innovation WeeklySign up here to join 17,000+ leaders getting Human-Centered Change & Innovation Weekly delivered to their inbox every week.

10 ways to overcome corporate immune surveillance

GUEST POST from Arlen Meyers

One of the many conundrums about cancer biology is why the body does not recognize abnormal, mutating cells as foreign and eliminate them. Biotech companies are starting to unravel the mystery and cancer immunotherapy is hot.

However, we have a much better understanding of the corporate immune system that has developed, over many years, the ability to sniff out innovation, troublemakers or those who pose a threat to the status quotidiens and nip it in the bud.

No alt text provided for this image

For intrapreneurs-employees trying to act like entrepreneurs in their organizations- they need to learn how to evade this highly developed and regulated corporate immune mechanism. Here are some tips:

1. Become a Trojan horse

2. Innovate your heart out. Just don’t let anyone know you are doing it until just the right time. Be sure you know when to ask for foregiveness instead of permission.

3. Intrapreneurship is guerilla warfare, not a full on frontal assault, so pick your weapons and strategy carefully,

4. Be sure you have good intelligence assets on the ground

5. Have Plan B

6. Be sure to give as many other people credit for your ideas as possible

7. Use words carefully. Call something by a name that does not raise the hair on the back of people’s heads, particularly in a different culture, like using “entrepreneur” or “marketing” in a clinical environment

8. Find a sponsor who can provide you with political cover

9. Bootstrap your idea for as long as possible. Asking for money puts you on the radar screen

10. Hide as many innovation surface receptors as possible so the corporate ligands can’t find you.

Here are some other survival tips for physician intrapreneurs.

Corporate anti-immunotherapy is evolving,but very slowly. It will take a long while before investors start throwing the same kind of money at it they are throwing at cancer immunotherapy. Keep your head down.

Subscribe to Human-Centered Change & Innovation WeeklySign up here to join 17,000+ leaders getting Human-Centered Change & Innovation Weekly delivered to their inbox every week.

Surveillance medicine

GUEST POST from Arlen Meyers

Harvard Professor Shoshana Zuboff took aim on tech giants like Facebook and Google when she wrote “The Age of Surveillance Capitalism”. Her thesis is that tech companies use our data, most of which we voluntarily relinquish, to steer us towards buying and using products and services and mold our behavior, labeling it a “virus”.

BIG DIGITAL HEALTH seems to have caught the bug. While Apple hasn’t made a move so drastic as acquiring Epic, the consumer tech titan continued to make headway on its strategy to democratize health information. We saw (mixed) results from the Apple Heart Study, the launch of new clinical studies using the Apple Watch, and an acquisition of Tueo Health for good measure.

Amazon’s joint venture with JP Morgan and Berkshire Hathaway got a name—Haven—and details emerged about its plans to scale to the broader insurance market. A year after purchasing PillPack, the tech giant ran into a prescription data wall and got its first vote of confidence from an insurer. Along the way, Amazon bought Health Navigator, Alexa learned some new healthcare skills, and AWS became a virtual medical scribe.

The conflict is between the potential benefits of digital health and digital therapeutics and the ethical threats and intrusions into our privacy and security.

Ethical issues abound in digital health as they apply to:

  1. personal health data
  2. artificial intelligence
  3. facial recognition
  4. reconciling the ethics of business with the ethics of medicine
  5. manipulating patients and doctors for profit
  6. conflict of interest and busted trust
  7. personal health information ownership rights
  8. social media mining for health applications
  9. biometric technologies
  10. Alexa spying

The bottom line: Your data is a valuable asset and is for sale online.

As patients begin to own their data, however, they will become digital health entrepreneurs and think twice about giving away such a valuable asset.

The space between the data and the doctor is being filled quickly with navigators, advocates and “infomediaries”. As responsibility for health outcomes increasingly shifts from doctors to patients, they become, in a sense, patient entrepreneurs, in possession of an asset-their data- creating value (better disease management and prevention) through the deployment and adoption of innovation. The result will be more DIY medicine and all that goes with it.

What’s more, the sharing economy is disintermediating the aforementioned intermediaries as patients become prosumers. But, picking your partner is about trust, something that seems to be busted in sickcare.

Think of APIs as tunnels into the clinical data warehouses that have been created by EHRs. Think of third parties as new and existing IT powerhouses — including the likes of Apple, Amazon, and Google — that have been authorized by patients to act as data stewards on their behalf.

We are not only democratizing care. We are democratizing and decentralizing value creation and funding. We are creating prosumers and accidental entrepreneurs.

What the result will be is anybody’s guess, but what is clear is that the rules, ecosystems, business models and technologies are inevitably facilitating more patient involvement, engagement and responsibility.

Amedzon has recently announced a service that will allow AI based algorithms to be applied to EMR data. Would you charge someone a fee to do that and place restrictions on its use if you owned your data?

Where you stand on whether digital health products add value or, as in the case of most digital health apps, are snake oil depends on where you sit.

At this point, though, it is unlikely that medical students and residents will be rotating on the surveillance medicine service.

Subscribe to Human-Centered Change & Innovation WeeklySign up here to join 17,000+ leaders getting Human-Centered Change & Innovation Weekly delivered to their inbox every week.

Recent advances in the diagnosis and treatment of innovation fatigue

GUEST POST from Arlen Meyers

Innovation Fatigue can be defined broadly as a negative impression of what is characterized as innovation caused by the overuse of the term, poorly-executed initiatives, internal misalignment and innovation for the sake of innovation. 

The etiologies of innovation fatigue are:

  1. Pervasive misuse of the term and confusing true innovation with an idea, an invention or an improvement
  2. Buying into the innovate or die mindset without creating the components necessary to do it
  3. Not having the knowledge, skills, attitudes and competencies to create it
  4. Repeated failures attempting to create it
  5. Cynicism about the ability to substantive change organization and systems that are traditionally highly resistant
  6. Frustration that leads to anger and resentment about the process
  7. Unwillingness to learn from other people and industries who have been successful creating truly innovative products and services
  8. Anxiety about the fear of missing out or the “I never saw it coming” syndrome
  9. Believing the press and cyberspace hype
  10. The bandwagon effect

Signs and symptoms of innovation fatigue are:

  1. Bloated budgets that do not translate into impact
  2. Misplace hires
  3. Spending more and more money on innovation initiatives without evidence that they work
  4. Attending programs, workshops and seminars that capitalize on fear and that do not change what you will do on Monday that you did or did not do on the previous Friday
  5. Buying products and services that have not been clinically validated
  6. It all becomes a joke
  7. Employees pretend to be engaged
  8. Resistance to change increases
  9. People say no
  10. People quit

Recent advances in treatment include:

  1. Recruiting for innovation
  2. Identifying champions with an entrepreneurial mindset
  3. Creating a culture of innovation
  4. Putting in place the leadership, strategy, tactics, structure, process and metrics
  5. Learning how to test business ideas
  1. Leading innovators instead of managing innovation
  2. Teaching innovation and entrepreneurship and intrapreneurship
  3. Understanding the definition of value
  4. Value proposition design
  5. Creating a VAST business model

Chronic innovation fatigue syndrome is endemic to geographic areas but is spreading rapidly. As yet, there is no vaccine to prevent activation of the corporate immune system that is a contributing factor.

Subscribe to Human-Centered Change & Innovation WeeklySign up here to join 17,000+ leaders getting Human-Centered Change & Innovation Weekly delivered to their inbox every week.

How to fund your biomedical or digital health startup

GUEST POST from Arlen Meyers

The most frequently asked question most inexperienced physician entrepreneurs ask is, “How do I find investors?”. The facts are that, according to the Angel Capital Association, only 2 percent of entrepreneurs are able to pry much-needed cash from the tight hands of angel investors, and less than a half of a percent raise money from venture capitalists, according to Price Waterhouse study.

Structural changes in the venture capital industry makes it harder to find seed stage money and investors who are willing and able to lead deals. The result is a seed stage gap.

Further complicating the issue is that investor ecosystems and funding requirements vary depending on the type of product or service you are building. For example, finding the amounts of money you will need to develop a drug, device or diagnostic product will vary significantly from how you find money for your digital health app or care delivery or service improvement. The time horizons and follow on round required are also different.

So, what’s a biofounder to do?

Here’s are the stages of funding.

Obviously, there is a lot of advice on how to raise seed stage money, but here are some recurrent themes concerning the strategy and tactics involved:

Strategy

1. Be sure your idea is ready for investor prime time–i.e. you have the pieces in place and have validated most of the elements of the your business model. The ultimate validation of your model will be if you have paying customers already.

2. Fight the right kind of investor who identifies with your idea during the right stage of development. Not all investors are the same. Some favor certain industries or products, some have personal connection, some want early stage, some want later stage. Do your homework. Here are the various stages of startup funding.

3. Explore alternative and new forms of funding, such as investor, charity or product/service crowdfunding, corporoate venture, state andlocal grants and university based endowments and investment funds.

.4. Network, network, network.

5. Fail early, often, and for as little cost as possible.

6. Self-fund or bootstrap for as long as possible. Build as much value into your idea as possible before shopping it to investors.

7. Consider customer-funded business models if possible.

8. Have a fundraising plan, just like a marketing plan or financial plan, and execute it

.9. Get the right people on the bus as soon as possible.

10. Find the cheapest, smartest capital (not necessarily money) to get to your next critical success factor.

Be sure you have a fundraising plan and follow these steps.

Tactics

Now that you have some strategy, here are some nuts and bolts:

1. Network, network, network.

2. Create a one-page executive summary, a 3-minute video, a website with a button “for investors” and a 10-slide Powerpoint presentation.

3. Sell to the heart, not to the head and be sure your pitch is investor ready.

4. Be sure you have the right story teller on the team.

5. Create social media buzz about your product or service as part of your plan. You know you are successful when an investor says, “Oh, I’ve heard of you.”

6. Apply for non-diluting sources of capital like SBIR/STTR, state and local eco-devo grants, international research, and development collaborations, etc.

7. Explore accelerators, generators, and incubators that have the right model for you.

8. Find out who funded your competitors and contact them.

9. Think big, but start small demonstrating customer traction with pilots.

10. Network,network, network. Even when you are networking, you might be mingling with the wrong people. There are 15 sources that you should cultivate who can make introductions or ease the way to meet investors.

11. Here is your angel investor contact to do list

Here are 10 other places to look for money:

You should also look into investor crowd funding. Here are the pros and cons.

Here are some tips on how to find angel investors:

  1. Use personal networking. The best angels you will find are the ones who know you personally, or know a member of your team or advisory board. If a potential investor gets to know you BEFORE you are asking for money, your credibility and investment probability will be improved by an order of magnitude.
  2. Entice angels to play along. Of course, angels are really mortals. They want to make a difference. Asking an angel to work with your company in an advisory role is a great way to establish a relationship that may lead to a cash investment. If you impress the angel, it will likely make her at least an archangel (advocate) when it comes to funding.
  3. Court local angel groups. Since angel investors most often focus only in their own geographic area, it’s most effective to court the local group, or even make a guest appearance with an archangel. If you can earn an archangel’s confidence, he or she will invite you to pitch the group, and you’ll have an edge in the voting.
  4. Mine national databases. If you are still alone, submit your application to the leading online website national databases of angel investors, Gust (USA) and National Angel Capital Association (Canada). These sites have arrangements with hundreds of local groups and individual investors that you might otherwise have missed. You might also check angel funds that target bioscience or digital health ideas or raise money from doctors for doctors.

Gust (formerly AngelSoft). This is perhaps the most widely-used source of information on angel investor groups across the world, run by the “Father of Angel Investing in New York,” David Rose. This software platform is used by many local angel organizations for managing deal flow.

Gust claims to have facilitated over $1 billion of investments in 500,000 startups to date, via connection through their platform to over 70,000 angel investors in 190 countries. As an entrepreneur, you simply use their investor search engine to find appropriate investors for your business according to location, industry interest, and other relevant criteria.

AngelList. This is another very popular website for raising equity or debt investments for startups. It was founded back in 2010 by Naval Ravikant and Babak Nivi of Venture Hacks, which is also a great place to visit for startup advice.

AngelList has featured over 3 million businesses for potential investors in a format that is, effectively, a social network for entrepreneurs and angels. They claim to have already raised over $560 million for 1400 startups, primarily in the US and Europe. In addition, they serve as a jobs available site for 24,000 startups.

Keiretsu Forum. This one claims to be the world’s largest single angel investor network, with 2500 accredited investor members throughout 52 chapters on 3 continents. Since its founding in 2000, its members have invested over $800 million dollars in over 800 companies in technology, consumer products, healthcare/life sciences, real estate and other segments with high growth potential.

The Founding Chapter is in Silicon Valley, California, (naturally). A caveat is that this is a for-profit organization, so fees to present may be significant.

USA Angel Investment Network. This group claims to be the largest angel investment community in the world. They have already raised $300 million for startups in the US and across the world. A caveat is that this network doesn’t offer a personal touch, as it only facilitates the exchange of contact information, so the matchmaking is left up to you.

The reach is very broad, with a network has 30 branches extending to 80 different countries. They have over 785,000 registered members with 140,000 investors and 650,000 entrepreneurs.

Angel Capital Association (ACA). The ACA is the angel industry alliance, which now includes a directory to more than 240 angel groups and 13,000 individual angels across North America. ACA member angel groups represent more than 10,000 accredited investors and are funding approximately 800 new companies each year, and managing an ongoing portfolio of more than 5,000 companies throughout North America. Here are some facts about angels:

  • Angels are still predominantly men, but the number of women angels has been increasing – 22 percent of angels are women and 30 percent of new angels are women;
  • Angels are based everywhere, not just in the Silicon Valley, Boston and New York;
  • Most angels are experienced entrepreneurs;
  • Median investment size is $25,000; and
  • A typical angel has a portfolio of 11 companies, with large variation depending on how long the angel has been investing.
  1. Remember angels beget angels. That means that once you get the first one, he or she becomes your best advocate for finding more. Investment angels don’t like to travel alone, so they will bring in others if they can (it’s called share the risk).
  2. Don’t forget passive angels. These are angel investors who are private, meaning they don’t go to meetings, but will invest if someone they trust brings them an attractive opportunity. Find the right investment advisor, or member of your advisory board, and the “match-making” will happen.

The VIC Investor Network helps develop and commercialize biomedical technologies that originate in academic research centers and government labs.

Apply for an SBIR/STTR grant for non-equity diluting funding. If you are successful, then apply for matching grants if they are offered in your state.

Apply to be part of an iCorps team.

Be sure you have a financial model is credible

Here are some ways to be sure you are ready for fundraising prime time.

Finding seed funding for your idea is as much about when and if as where and how. It takes planning, preparation and practice and having realistic expectations about how few companies actually are funded by VCs, angels and crowd funding platforms. Be sure you have done your homework, crafted, and validated your business model canvas and done some experiments before giving up control to investors. Good luck with your venture.

Subscribe to Human-Centered Change & Innovation WeeklySign up here to join 17,000+ leaders getting Human-Centered Change & Innovation Weekly delivered to their inbox every week.

How to teach doctors customer service

GUEST POST from Arlen Meyers

By now, if you have anything to do with taking care of patients, you have been bombarded with posts, blogs, white papers and seminars on customer service. The customer experience is not just about the patient, but also includes anyone who interacts or touches the patient in their care journey, including clinical, administrative, clerical and support staff.

More and more, doctors and other medical staff are being measured, held accountable for and compensated, in part, on their customer service skills, and, for good reason.

A study of nearly 35,000 online reviews of physicians nationwide has found that customer service is patients’ chief frustration, not physicians’ medical expertise and clinical skill.

The study, published in the current issue of the Journal of Medical Practice Management, reveals that 96 percent of patient complaints are related to customer service, while only 4 percent are about the quality of clinical care or misdiagnoses.

In summary, the study found that fewer than 1 in 20 online complaints cite diagnosis, treatments and outcomes in healthcare as unsatisfactory, whereas more than 19 of 20 unhappy patients said inadequate communications and disorganized operations drove them to post harsh reviews.

Despite assertions to the contrary, digital health interventions aren’t helping.

The problem, like so many other other demands placed on the clinical staff, like being expected to innovate, is that they are not taught how to do it. The result is frustration, push back and burnout. Here’s how to piss off your patients.

If you are like most, you probably hate customer service and companies seem to be doing little or nothing to make it better.

A recent article explains why and stresses that the experience should derive from your brand identity, the defining values and attributes that distinguish a brand.

Like building a house, the author suggests that you need to build a blueprint and a customer experience architecture in 7 steps:

To develop a customer experience architecture, follow these steps:

1. The brand platform — First, define or reaffirm the overarching ideas that represent the brand. REI’s brand platform is the excitement and adventure of the outdoors; Chick-fil-A’s is exceeding customers’ expectations with a servant’s spirit.

2. Customer experience strategy — Then describe the desired customer feelings and perceptions of the brand across all interactions with the organization. An electronics website might want to create a “place” for customers to discover and be delighted by innovations. A hotelier might want customers to feel pampered by legendary service. Most patients simply want to feel like caregivers care and that they are safe.

3. Business segmentation — The next step is to break down the business into discrete units. For a new brand, segmenting the business by traffic vs. trial vs. transition might be an illuminating approach; a restaurant company might segment by service mode, e.g., eat-in vs. drive-thru vs. carry-out; and a product-line segmentation might be appropriate for a manufacturer. The objective is to identify the different experiences the organization delivers and to articulate the requirements and objectives of each.

4. Customer segmentation — Different target segments have different needs — some customers may value convenience over price, others may be looking for an entertaining experience — so their desired experiences vary. Describe each segment with a profile and a needs inventory, including key drivers of purchase decisions and brand perceptions.

5. Prioritization — Create a grid with the business segments as columns and customer segments as rows. Each business/customer intersection represents a discrete experience to design and deliver. They should be prioritized in order to focus design and management. Prioritization criteria include profit potential, fit with long-term strategy, competitive advantage and differentiation, resource requirements, and how the experience affects and/or reinforces brand values and brand position.

6. Experience design — Determine how to meet the segment-specific needs in each business segment, either by improving existing approaches based on new insights from the architecture or by developing entirely new ones. All the levers of customer experience — product, service, content, channels, touchpoints, pricing, facilities, sensory engagement, etc. — should be considered and described in the design.

7. Assessment and integration — Now the architecture is ready to be inspected for integrity and coherence. Is the brand platform expressed throughout every experience? Do the discrete experiences contribute to the overall customer experience strategy? Do experiences complement and enhance each other, or do they conflict or detract from each other?

Some argue that the hospitality industry is not the appropriate model for the sick care systems business and that we need to fix how we do care coordination and communication and teach pathetic doctors how to be empathetic.

Here’s a test on patient experience at your place:

1. Was it easy to find a place to park?

2. How many times were you handed a clipboard?

3. How long did you have to wait to get an appointment?

4. How long did you sit in the reception area/waiting room?

5. Was there free WIFI in the reception area ?

6. How long did it take for you to get your test results? Did someone send them to you or was it your responsibility to get them?

7. Was the coffee in the lobby overpriced or free?

8. Were you charged to get a copy of your records and was it more than what it would cost at Staples?

9. Were you able to find your doctor’s office easily or did you have to ask someone for directions?

10. Do you remember the names of the people who took care of you?

11. Does everybody really care or, are they too burned out to do so?

So, if doctors are expected to improve their customer service skills, how should we do it?

Here are some guidelines that should inform how we teach and measure doctor customer service:

  1. Changing behavior is hard and involves identifying the undesired behavior, targeting triggers, measuring the response and creating carrots or sticks to eliminate or reinforce the behavior
  2. Unless the changed behavior becomes a habit through repetition, education and training, there is a high rate of recidivism
  3. Many doctors are simply unwilling or unable to change and they need to be “rehabilitated” or fired accordingly. Instead, many just get promoted to the C suite.
  4. Delegating the responsibility to managers or department heads to create customer service improvement does not work without following a delegation process
  5. The process of gathering feedback and using it to guide improvement likewise must be done correctly to make a difference.
  6. There is little or no correlation with patient experience and the quality of medical inputs and outcomes
  7. Improving experience is but one step towards engagement and enabling changes into value added modifications of patient and medical team behavior
  8. The cost, time and effort of using sophisticated customer experience vendor solutions can be prohibitive and, instead, require some bootstrapped solutions to solve targeted problems eminating from targeted people in certain departments, who, most likely, are the 20% creating 80% of the problems
  9. Often times, because managers themselves are not trained or proficient in customer service, the blind are leading the blind
  10. It is an unrealistic expectation for a doctor to have the diagnostic skills of Osler, the technical genius of Leonardo, the compassion and empathy of Mother Theresa and the customer service skills of the bartender at the Ritz Carlton. We need to be realistic about setting acceptable standards that recognize individual strengths and weaknesses and how we recruit for them.
  11. Establish guidelines and pathways for dealing with difficult patients and chronic complainers. When and how should you inform a patient that they should get care somewhere else if they are so dissatisfied with the service or experience.
  12. Manage online complaints and create a reputation management protocol and platform.

We used to tell substance abusers to just say no and that didn’t work out so well.. Unfortunately, just telling sickcare workers to follow the golden rule has not worked either.

Subscribe to Human-Centered Change & Innovation WeeklySign up here to join 17,000+ leaders getting Human-Centered Change & Innovation Weekly delivered to their inbox every week.

Digital Biopharma 2.0

GUEST POST from Arlen Meyers

Digital health has converged with biopharma. It has happened because digital health technologies are making it easier for biopharmaceutical companies to discover, develop and launch new drugs faster and cheaper and improve the patient and doctor experience, in what is being labeled “after the pill”,

U.S. regulators have approved the first digital pill with an embedded sensor to track if patients are taking their medication properly, marking a significant step forward in the convergence of healthcare and technology. Some, however, are voicing concerns that there is no evidence that digital pills, prescription medications with ingestible wireless sensors, are beneficial to patients and, in fact, the technology poses a danger to the provider-patient relationship.

Increasingly, we are seeing the results of the intersection of digital health, biopharma and medtech. Here is an update on digital health pharma news.

What do the next stage of pharma and digital health collaborations look like?

Recent medical developments have gone towards personalized healthcare, meaning that patients get individualized treatments for their specific needs and also manage their disease.

Buzzwords that come to my mind in this context include big data, artificial intelligence, closed loop systems (not only for diabetes), and precision medicine.

Here are the results of a recent survey about the use of digital health in biopharma.

There are many applications:

  1. Drug discovery and development using community based innovation networks
  2. Better clinical trial recruitment, retention and execution that are more patient centric
  3. Physician engagement at the community level as well as the academic research level
  4. Patient engagement, compliance and adherence
  5. Information and education

Here’s how digital health technologies are helping patients with diabetes and hypertension.

6. Remote sensing, data and analytics. For example, Pittsburgh-based UPMC Enterprises has made an equity investment in RxAnte, a predictive analytics and clinical intervention solution provider focused on inappropriate medication use.

RxAnte uses predictive analytics to improve prescribing practices and appropriate use of prescription medications.

7. Post market surveillance and pharmacovigilence

8. Sales and marketing

9. Personalized and precision medicine

10 Price and effectiveness transparency

11.Drug delivery

12. Smart pills

In addition, artificial intelligence, machine learning, the internet of medical things, remote patient monitoring, patient reported outcomes and blockchain technologies have the potential to improve the research quotient of biopharma drug discovery and development.

A recent HIMMS panel showcased the challenges:

The world is changing for Big Pharma. Driven by value-based care, reimbursement will increasingly be tied to drug effectiveness and outcomes. Competition is growing and market share slipping. To offset these challenges, pharma must forge new strategic alliances, drive efficiencies, speed up clinical trials, and develop targeted therapies as healthcare moves to more personalized care and precision medicine. Technology will drive this paradigm shift.

Here is how one company is rethinking how to engage with HCPs and digital health startups.

3 predictions for AI in pharma R&D in the year ahead:

Prediction 1: Drug discovery is being redefined by advances in technology. AI and machine learning software is expanding the universe of screenable compounds and will deliver higher hit rates as compounds move through the pharma value chain. The race is on for data. Consequently, BIG PHARMA will need to do a better job removing the barriers to collaboration with digital health (physician and patient) entrepreneurs.

Prediction 2: Within the next 10 years, a blockbuster-potential drug will emerge from a process that started with a computer, then to bench, then to clinic. We will see within the next few years promising compounds enter the FDA pipeline.

Prediction 3: Pharma companies will step up M&A, investment and joint venture activity this year and in 2019 as they look to the world of software AI startups for new drug discovery capabilities. The tailwinds are there for tremendous value creation.

Going beyond the pill will also require new business models and faces the challenges of precision medicine. Within the last few years the FDA has undergone a metamorphosis when it comes to digital health regulations. Though many of these are not yet solidified, a recent report by PricewaterhouseCoopers(PwC) predicts that these changes could open new doors for pharmaceutical companies looking to jump into the digital arena. The report spelled out four main regulatory changes that could give pharma a chance to accelerate digital product development.

First, the report points to the new digital health pre-certification program, which looks to allow certain companies that the FDA has deemed responsible and safe in their development to build products without each new device undergoing the FDA clearance or approval process.

Secondly, the agency proposed a new change that could make it easier for pharma companies to release medication companion apps. The report outlines that the proposal would allow digital tools, which supplement prescription drugs, to be regulated as labeling instead of going through their own process.

It also points to a newly published FDA draft guidance that applies to multiple function devices, which the FDA will “treat as separate the various functions of a digital health device, making it easier to have full-function products.”

Lastly, it highlights an over the counter (OTC) drug digital labeling regulations draft guidance, which allows the OTC drugs to be “approved based on evidence that consumers can use digital labeling to select a drug for treatment.”

Using digital tools to innovate has moved biopharmaceutical companies to create a new

position: chief digital officer and they are developing best practices.

All of these opportunities will challenge STEM graduate and medical school educators and leaders to create new learning objectives that provide the new and necessary competencies for graduates to compete in these evolving industries, particularly in the areas of data science, analytics, mining unstructured data and intelligence. Some universities and health systems, like the University of Colorado, are doing just that.

Digital health technologies are changing not only the face of clinical practice entrepreneurship, but medtech and biopharma as well. Given the pace of change, we are likely to see Digital Biopharma 2.0 and Digital Medtech 2.0 in the blink of an app. In fact, we might already have missed it.

 
Image by Arek Socha from Pixabay

Subscribe to Human-Centered Change & Innovation WeeklySign up here to join 17,000+ leaders getting Human-Centered Change & Innovation Weekly delivered to their inbox every week.

How to screw up the experience survery

GUEST POST from Arlen Meyers

I recently spent a day in New York City. The weather was dreary so it was a perfect day to see a Broadway matinee. Of course, no one wants to pay those Broadway prices. Down the street from the hotel, there was a theater company so I asked the in-the-know locals at the reception desk about the best way to get discount last minute tickets to a show within walking distance without standing in the rain at the kiosk in Times Square. They suggested an app.

Sure enough, I bought a ticket on the app at a substantial discount to a theater about 6 blocks away. The lead deserved his Tony nomination.

The next day I received an email asking me to do a survey about my experience and offered to enter me into a lottery for a $100 coupon if I completed it.. Imagine if sick care professionals or hospitals did that after your visit? When was the last time you got one after a drug rep or MSL or device rep visited you in your office or the OR?

Unfortunately, after entering the answer to the first question, I logged off and deleted the app. Here’s why:

  1. There were too many questions
  2. The website took too long to respond
  3. I had to click through too many fields
  4. I was worried that by participating I would be continually annoyed with subsequent emails.
  5. I didn’t trust the site enough to know what they would do with the data or how much money they would make selling it to someone without my permission
  6. This was a one-off experience. Since I was visiting from out of town, it is unlikely I’ll be using them again in the near future. The life time value of my engagement is slim.
  7. I wasn’t sure why they were asking me certain questions
  8. The survey was boring
  9. There wasn’t anything personal about it. In this day and age of AI, that’s unimaginable.
  10. They could have accomplished the same thing with a single answer net promoter score. However, it they did, it might not tell them whether users intentions actually correlated with with whether they did or did not recommend the product.

Improving the sickcare customer experience has become a growth industry as convenience, experience, service, access and digital tools become more important to patients and healthcare professionals who are used to the convenience of other industries.

Best practices include:

  1. Provide one complete view of the customer experience
  2. Capture information continuously
  3. Ensure feedback reflects the customer base
  4. Make it easy for customers to give feedback
  5. Provide customer feedback to every employee
  6. Tailor information to the needs of each role
  7. Link feedback to customer, operational and financial data
  8. Understand the financial impact of customer data
  9. Lead with a customer centric strategy
  10. Define clear customer experience responsibilities, goal and success metrics
  11. Reinforce the right customer-centric behaviors
  12. Close the loop with customers on a systematic basis
  13. Surface high-impact opportunities for improvement
  14. Address the root cause of problems, not just symptoms
  15. Leverage scale to unconver effective practices
  16. Test and validate product and service innovations

The ultimate goal is to use information to  change the  behavior of those who care for patients. In some instances, providing feedback is enough. In others, it is not and can present substantial challenges, including how and when to terminate an employee.

When it comes to obtaining customer input, executives often think a multiple-choice survey will be the most cost-effective option. They have their place, of course, such as if you want to know the percentage of people who liked or disliked something. But these instruments are shallow and derivative at best, and at their worst they can be annoying and counterproductive. So don’t let them become an excuse for not talking to the customer.

I must not be alone, given that the response rate to external surveys is 10-15%. Here’s how to avoid all of these mistakes. Enjoy the show. Delete the survey.

Subscribe to Human-Centered Change & Innovation WeeklySign up here to join 17,000+ leaders getting Human-Centered Change & Innovation Weekly delivered to their inbox every week.

The two faces of necessity-based entrepreneurship

GUEST POST from Arlen Meyers

When companies like Uber move into an area, some people there are less likely to start businesses of their own. The falloff may reflect a decline in “necessity-based entrepreneurship” by unemployed or underemployed people. If they have no job opportunities, “they’re more likely to act on what’s potentially a lower-quality startup idea” that doesn’t get much support on Kickstarter.

About half of Uber drivers have college degrees. What is the lost entrepreneurial cost?

More and more doctors are getting interested in entrepreneurship i.e. the pursuit of opportunity under conditions of uncertainty with the goal of creating user defined value through the deployment of innovation using a VAST business model. Some are doing it because they think they have to given threats to their incomes, change fatigue and fear. While those factors can be strong entrepreneurial motivators, there are also pitfalls:

  1. Getting involved without a clear understanding of the entrepreneurial knowledge, skills, abilities and competencies required to add value.
  2. Making decisions based on reflexive emotions instead of reflective decision making
  3. Taking short cuts
  4. Undervaluing your worth to get a side gig
  5. Participating in ventures that have a low chance of success
  6. Quitting your day job before you should
  7. Putting too many eggs in one basket
  8. Over promising and under delivering
  9. Making bad investment decisions
  10. Making burnout worse by losing even more control

Like Janus, necessity-based entrepreneurship has two faces. While it is said that necessity is the mother of invention, it leaves many ideas, inventions and discoveries as orphans as well.

Which face you show should be something that is by design, not by necessity. So here’s to financial stress and deadline pressure, even if few of us can be Marx or Dickens. To paraphrase Tiny Tim, God bless ‘em, every one.

Subscribe to Human-Centered Change & Innovation WeeklySign up here to join 17,000+ leaders getting Human-Centered Change & Innovation Weekly delivered to their inbox every week.

Recent advances in pharmapreneurship education and training

GUEST POST from Arlen Meyers

Pharmacy educators, like other health professional educators, have realized that they need to educate and train graduates with better critical thinking skills, spur more creativity and innovation and graduate students with an entrepreneurial mindset, since, that’s where innovation starts.

Here’s how one panel defines a pharmapreneur and the KSAs and competentices required to be successful.

The entrepreneurial mindset is different from the clinical mindset.

Consequently, pharmacy educators and professional associations are rushing to to meet the need and add value to their members and graduates:

  1. Bioentrepreneurship education and training courses
  2. Dual degree and certificate offerings
  3. Pharmacy entrepreneurs in residence
  4. Better seed stage funding mechanisms, including those from pharma philanthropreneurs and corporate venture sites
  5. Interdisciplinary Professional Education programs
  6. Pharmapreneur pharmacy student groups
  7. Pharmapreneur Shark Tank competitions
  8. Recognition of the scholarship of innovation for promotion and tenure credit.
  9. Preceptorships and apprenticeships with biomedical startups
  10. Alternative career development tracks for those interested in non-clinical careers
  11. Better mentoring and network development
  12. Career fairs
  13. Education on drug supply chain management, tracking and security
  14. Pharmacy merchandising
  15. Asset protection and risk management

We need more primary care pharmacists and interprofessional sick care entrepreneurship

Rapid changes in sick care delivery are creating many new clinical and non-clinical opportunities for pharmacists. When linked with similar programs for medical, nursing, dental and graduates student efforts, synergies and economies of scale will result in a more capable workforce dedicated to creating user defined value through the deployment of biomedical and clinical innovation using a VAST business model.

Subscribe to Human-Centered Change & Innovation WeeklySign up here to join 17,000+ leaders getting Human-Centered Change & Innovation Weekly delivered to their inbox every week.